1 Market Overview

1.1 Product Overview and Scope of COVID-19 In-Vitro Diagnostics

1.2 Classification of COVID-19 In-Vitro Diagnostics by Type

1.2.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2020

1.2.3 Rapid Diagnostic Test (RDT)

1.2.4 Enzyme Linked Immunosorbent Assay (ELISA)

1.2.5 Neutralization Assay

1.3 Global COVID-19 In-Vitro Diagnostics Market by Application

1.3.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Home

1.3.3 Hospital

1.3.4 Clinical

1.4 Global COVID-19 In-Vitro Diagnostics Market Size & Forecast

1.5 Global COVID-19 In-Vitro Diagnostics Market Size and Forecast by Region

1.5.1 Global COVID-19 In-Vitro Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global COVID-19 In-Vitro Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe COVID-19 In-Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific COVID-19 In-Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa COVID-19 In-Vitro Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 COVID-19 In-Vitro Diagnostics Market Drivers

1.6.2 COVID-19 In-Vitro Diagnostics Market Restraints

1.6.3 COVID-19 In-Vitro Diagnostics Trends Analysis

2 Company Profiles

2.1 Cellex

2.1.1 Cellex Details

2.1.2 Cellex Major Business

2.1.3 Cellex COVID-19 In-Vitro Diagnostics Product and Solutions

2.1.4 Cellex COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Cellex Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott COVID-19 In-Vitro Diagnostics Product and Solutions

2.2.4 Abbott COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Roche

2.3.1 Roche Details

2.3.2 Roche Major Business

2.3.3 Roche COVID-19 In-Vitro Diagnostics Product and Solutions

2.3.4 Roche COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Roche Recent Developments and Future Plans

2.4 BioMedomics

2.4.1 BioMedomics Details

2.4.2 BioMedomics Major Business

2.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions

2.4.4 BioMedomics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 BioMedomics Recent Developments and Future Plans

2.5 BD

2.5.1 BD Details

2.5.2 BD Major Business

2.5.3 BD COVID-19 In-Vitro Diagnostics Product and Solutions

2.5.4 BD COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BD Recent Developments and Future Plans

2.6 Henry Schein

2.6.1 Henry Schein Details

2.6.2 Henry Schein Major Business

2.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions

2.6.4 Henry Schein COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Henry Schein Recent Developments and Future Plans

2.7 Safecare Bio-Tech

2.7.1 Safecare Bio-Tech Details

2.7.2 Safecare Bio-Tech Major Business

2.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions

2.7.4 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Safecare Bio-Tech Recent Developments and Future Plans

2.8 Mayo Clinic Laboratories

2.8.1 Mayo Clinic Laboratories Details

2.8.2 Mayo Clinic Laboratories Major Business

2.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions

2.8.4 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mayo Clinic Laboratories Recent Developments and Future Plans

2.9 Chembio Diagnostics

2.9.1 Chembio Diagnostics Details

2.9.2 Chembio Diagnostics Major Business

2.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions

2.9.4 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Chembio Diagnostics Recent Developments and Future Plans

2.10 Mount Sinai Laboratory

2.10.1 Mount Sinai Laboratory Details

2.10.2 Mount Sinai Laboratory Major Business

2.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions

2.10.4 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Mount Sinai Laboratory Recent Developments and Future Plans

2.11 Ortho Clinical Diagnostics

2.11.1 Ortho Clinical Diagnostics Details

2.11.2 Ortho Clinical Diagnostics Major Business

2.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions

2.11.4 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Ortho Clinical Diagnostics Recent Developments and Future Plans

2.12 Zhejiang Orient Gene Biotech

2.12.1 Zhejiang Orient Gene Biotech Details

2.12.2 Zhejiang Orient Gene Biotech Major Business

2.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions

2.12.4 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Zhejiang Orient Gene Biotech Recent Developments and Future Plans

2.13 Innovita Biological Technology

2.13.1 Innovita Biological Technology Details

2.13.2 Innovita Biological Technology Major Business

2.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions

2.13.4 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Innovita Biological Technology Recent Developments and Future Plans

2.14 Guangzhou Wondfo Biotech

2.14.1 Guangzhou Wondfo Biotech Details

2.14.2 Guangzhou Wondfo Biotech Major Business

2.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions

2.14.4 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans

2.15 Guangdong Hecin-Scientific

2.15.1 Guangdong Hecin-Scientific Details

2.15.2 Guangdong Hecin-Scientific Major Business

2.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions

2.15.4 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Guangdong Hecin-Scientific Recent Developments and Future Plans

2.16 Dynamiker Biotechnology (Tianjin)

2.16.1 Dynamiker Biotechnology (Tianjin) Details

2.16.2 Dynamiker Biotechnology (Tianjin) Major Business

2.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions

2.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans

2.17 ADVAITE

2.17.1 ADVAITE Details

2.17.2 ADVAITE Major Business

2.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions

2.17.4 ADVAITE COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 ADVAITE Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COVID-19 In-Vitro Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 COVID-19 In-Vitro Diagnostics Players Market Share

3.2.2 Top 10 COVID-19 In-Vitro Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global COVID-19 In-Vitro Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global COVID-19 In-Vitro Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2016-2021)

5.2 COVID-19 In-Vitro Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2026)

6.2 North America COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2026)

6.3 North America COVID-19 In-Vitro Diagnostics Market Size by Country

6.3.1 North America COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2026)

6.3.2 United States COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2026)

7.2 Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2026)

7.3 Europe COVID-19 In-Vitro Diagnostics Market Size by Country

7.3.1 Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific COVID-19 In-Vitro Diagnostics Market Size by Region

8.3.1 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2016-2026)

8.3.2 China COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2026)

9.2 South America COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2026)

9.3 South America COVID-19 In-Vitro Diagnostics Market Size by Country

9.3.1 South America COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa COVID-19 In-Vitro Diagnostics Market Size by Country

10.3.1 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE COVID-19 In-Vitro Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global COVID-19 In-Vitro Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global COVID-19 In-Vitro Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market COVID-19 In-Vitro Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global COVID-19 In-Vitro Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. Cellex Corporate Information, Head Office, and Major Competitors

Table 7. Cellex Major Business

Table 8. Cellex COVID-19 In-Vitro Diagnostics Product and Solutions

Table 9. Cellex COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott COVID-19 In-Vitro Diagnostics Product and Solutions

Table 13. Abbott COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Roche Corporate Information, Head Office, and Major Competitors

Table 15. Roche Major Business

Table 16. Roche COVID-19 In-Vitro Diagnostics Product and Solutions

Table 17. Roche COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. BioMedomics Corporate Information, Head Office, and Major Competitors

Table 19. BioMedomics Major Business

Table 20. BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions

Table 21. BioMedomics COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BD Corporate Information, Head Office, and Major Competitors

Table 23. BD Major Business

Table 24. BD COVID-19 In-Vitro Diagnostics Product and Solutions

Table 25. BD COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Henry Schein Corporate Information, Head Office, and Major Competitors

Table 27. Henry Schein Major Business

Table 28. Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions

Table 29. Henry Schein COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Safecare Bio-Tech Corporate Information, Head Office, and Major Competitors

Table 31. Safecare Bio-Tech Major Business

Table 32. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions

Table 33. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mayo Clinic Laboratories Corporate Information, Head Office, and Major Competitors

Table 35. Mayo Clinic Laboratories Major Business

Table 36. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions

Table 37. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors

Table 39. Chembio Diagnostics Major Business

Table 40. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions

Table 41. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Mount Sinai Laboratory Corporate Information, Head Office, and Major Competitors

Table 43. Mount Sinai Laboratory Major Business

Table 44. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions

Table 45. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors

Table 47. Ortho Clinical Diagnostics Major Business

Table 48. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions

Table 49. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Zhejiang Orient Gene Biotech Corporate Information, Head Office, and Major Competitors

Table 51. Zhejiang Orient Gene Biotech Major Business

Table 52. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions

Table 53. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Innovita Biological Technology Corporate Information, Head Office, and Major Competitors

Table 55. Innovita Biological Technology Major Business

Table 56. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions

Table 57. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors

Table 59. Guangzhou Wondfo Biotech Major Business

Table 60. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions

Table 61. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Guangdong Hecin-Scientific Corporate Information, Head Office, and Major Competitors

Table 63. Guangdong Hecin-Scientific Major Business

Table 64. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions

Table 65. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Dynamiker Biotechnology (Tianjin) Corporate Information, Head Office, and Major Competitors

Table 67. Dynamiker Biotechnology (Tianjin) Major Business

Table 68. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions

Table 69. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. ADVAITE Corporate Information, Head Office, and Major Competitors

Table 71. ADVAITE Major Business

Table 72. ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions

Table 73. ADVAITE COVID-19 In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global COVID-19 In-Vitro Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 75. Global COVID-19 In-Vitro Diagnostics Revenue Share by Players (2019-2021)

Table 76. Breakdown of COVID-19 In-Vitro Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided

Table 78. COVID-19 In-Vitro Diagnostics Mergers & Acquisitions in the Past Five Years

Table 79. COVID-19 In-Vitro Diagnostics New Entrants and Expansion Plans

Table 80. Global COVID-19 In-Vitro Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 81. Global COVID-19 In-Vitro Diagnostics Revenue Share by Type (2016-2021)

Table 82. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Type (2021-2026)

Table 83. Global COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021)

Table 84. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Application (2021-2026)

Table 85. North America COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 86. North America COVID-19 In-Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 87. North America COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 88. North America COVID-19 In-Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 89. North America COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 90. North America COVID-19 In-Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 103. South America COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 104. South America COVID-19 In-Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 105. South America COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 106. South America COVID-19 In-Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 107. South America COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 108. South America COVID-19 In-Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. COVID-19 In-Vitro Diagnostics Picture

Figure 2. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2020

Figure 3. Rapid Diagnostic Test (RDT)

Figure 4. Enzyme Linked Immunosorbent Assay (ELISA)

Figure 5. Neutralization Assay

Figure 6. COVID-19 In-Vitro Diagnostics Revenue Market Share by Application in 2020

Figure 7. Home Picture

Figure 8. Hospital Picture

Figure 9. Clinical Picture

Figure 10. Global COVID-19 In-Vitro Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global COVID-19 In-Vitro Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2016-2026)

Figure 13. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region in 2020

Figure 14. North America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. COVID-19 In-Vitro Diagnostics Market Drivers

Figure 20. COVID-19 In-Vitro Diagnostics Market Restraints

Figure 21. COVID-19 In-Vitro Diagnostics Market Trends

Figure 22. Cellex Recent Developments and Future Plans

Figure 23. Abbott Recent Developments and Future Plans

Figure 24. Roche Recent Developments and Future Plans

Figure 25. BioMedomics Recent Developments and Future Plans

Figure 26. BD Recent Developments and Future Plans

Figure 27. Henry Schein Recent Developments and Future Plans

Figure 28. Safecare Bio-Tech Recent Developments and Future Plans

Figure 29. Mayo Clinic Laboratories Recent Developments and Future Plans

Figure 30. Chembio Diagnostics Recent Developments and Future Plans

Figure 31. Mount Sinai Laboratory Recent Developments and Future Plans

Figure 32. Ortho Clinical Diagnostics Recent Developments and Future Plans

Figure 33. Zhejiang Orient Gene Biotech Recent Developments and Future Plans

Figure 34. Innovita Biological Technology Recent Developments and Future Plans

Figure 35. Guangzhou Wondfo Biotech Recent Developments and Future Plans

Figure 36. Guangdong Hecin-Scientific Recent Developments and Future Plans

Figure 37. Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans

Figure 38. ADVAITE Recent Developments and Future Plans

Figure 39. Global COVID-19 In-Vitro Diagnostics Revenue Share by Players in 2020

Figure 40. COVID-19 In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players COVID-19 In-Vitro Diagnostics Revenue Market Share in 2020

Figure 42. Global Top 10 Players COVID-19 In-Vitro Diagnostics Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global COVID-19 In-Vitro Diagnostics Revenue Share by Type in 2020

Figure 45. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Type (2021-2026)

Figure 46. Global COVID-19 In-Vitro Diagnostics Revenue Share by Application in 2020

Figure 47. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Application (2021-2026)

Figure 48. North America COVID-19 In-Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 49. North America COVID-19 In-Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 50. North America COVID-19 In-Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 51. United States COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe COVID-19 In-Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 55. Europe COVID-19 In-Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 56. Europe COVID-19 In-Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 57. Germany COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific COVID-19 In-Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific COVID-19 In-Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2016-2026)

Figure 65. China COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America COVID-19 In-Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 72. South America COVID-19 In-Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 73. South America COVID-19 In-Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 74. Brazil COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa COVID-19 In-Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa COVID-19 In-Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 79. Turkey COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source